PRESS RELEASE published on 04/10/2025 at 19:15, 1 year ago Declaration made pursuant to Article L. 233-8-II of the French Commercial Code and Article 223-16 of the General Regulation of the Autorité des Marchés Financiers SCOR, a leading global reinsurer, offers diversified reinsurance and insurance solutions applying 'The Art & Science of Risk', serving clients in 150+ countries Risk Management Global Insurance Solutions SCOR Reinsurer
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year ago Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments Immunic, Inc. closes $5.1 million direct offering led by Aberdeen Investments to fund clinical trials and operations for autoimmune diseases. Issued via PRNewswire Clinical Trials Immunic Inc. Autoimmune Diseases Direct Offering Aberdeen Investments
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year ago D. Boral Capital Acted as Sole Bookrunner to FatPipe, Inc. (Nasdaq: FATN) in Connection with its $4.0 Million Initial Public Offering FatPipe, Inc. closes IPO, trading on Nasdaq under ticker symbol FATN. D. Boral Capital LLC acts as Book-Running Manager. Sichenzia Ross Ference Carmel LLP and Lucosky Brookman LLP provide legal counsel Nasdaq IPO FatPipe Inc. D. Boral Capital LLC Sichenzia Ross Ference Carmel LLP
PRESS RELEASE published on 04/10/2025 at 19:00, 1 year ago Inside Information / Other news releases TME Pharma increases resources for liquidity contract with Invest Securities by €5,000 to support cash balance and securities. Details of shares and cash balance provided Liquidity Contract INVEST SECURITIES Clinical-stage Biotechnology Resources TME Pharma
PRESS RELEASE published on 04/10/2025 at 18:57, 1 year ago EQS-Adhoc: HAMBORNER REIT AG: Adjustment of dividend strategy HAMBORNER REIT AG announced an adjustment to its dividend strategy, reducing the payout ratio to 60%-70% of the operating result. The 2025 dividend is forecasted at €0.33-€0.39 per share HAMBORNER REIT AG Payout Ratio Dividend Strategy 2025 Financial Year Dividend Forecast
PRESS RELEASE published on 04/10/2025 at 18:28, 1 year ago Travis Perkins: Director/PDMR Shareholding Travis Perkins plc announces exercise and sale of ordinary shares by PDMR Robin Miller to meet tax liabilities. Notification under UK Market Abuse Regulation Ordinary Shares PDMR UK Market Abuse Regulation Travis Perkins Plc Exercise Of Options
PRESS RELEASE published on 04/10/2025 at 18:19, 1 year ago Fuller, Smith & Turner PLC: Transaction in own shares Fuller, Smith & Turner PLC announces purchase of own shares as part of share buyback programme on 10-Apr-2025 London Stock Exchange Fuller, Smith & Turner PLC Share Buyback Programme Numis Securities Limited Own Shares
PRESS RELEASE published on 04/10/2025 at 18:15, 1 year ago EQS-Adhoc: SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed capital market expectations SCHOTT Pharma AG & Co. KGaA exceeds Q2 2025 expectations with EUR 252m revenues, EUR 72m EBITDA, and 28.6% EBITDA margin, maintaining full-year guidance. Detailed results on May 15, 2025 Revenues EBITDA SCHOTT Pharma Full-year Guidance Q2 2025
PRESS RELEASE published on 04/10/2025 at 18:15, 1 year ago Hypergrowth in recurring business and turnover in Q1 2025 WALLIX reports strong Q1 2025 performance with 27.3% MRR growth, 22.2% turnover increase, and confirmation of 2025 financial targets Financial Targets WALLIX Recurring Business Q1 2025 MRR Growth
PRESS RELEASE published on 04/10/2025 at 18:12, 1 year ago Galenica Annual General Meeting approves all motions and elects new member of the Board of Directors Galenica Annual General Meeting approves all motions, elects new Board member, and approves dividend increase. Shareholders demonstrate confidence in leadership and strategic direction Board Of Directors Annual General Meeting Dividend Increase AGM Galenica
Published on 05/09/2026 at 01:30, 2 hours 43 minutes ago Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 4 hours 13 minutes ago Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 20:38, 7 hours 35 minutes ago EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 9 hours 1 minute ago EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026
Published on 05/08/2026 at 19:02, 9 hours 11 minutes ago Metall Zug – Annual General Meeting of Shareholders approves all proposals
Published on 05/07/2026 at 19:15, 1 day 8 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:06, 1 day 9 hours ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 18:17, 1 day 9 hours ago DESCRIPTION OF THE LOUIS HACHETTE GROUP SHARE BUYBACK PROGRAM 2026-2027
Published on 05/07/2026 at 17:45, 1 day 10 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL